We are live on ! Find out more
Andreas Halvorsen

Andreas Halvorsen Viking Global Investors

AUM $32.7B Turnover 51.75%
1-Year Est. Return 11.24%
 

Andreas Halvorsen is the founder of Viking Global Investors, another prominent firm with roots in Julian Robertson’s Tiger Management. Viking is known for fundamental long/short equity investing and a large, research-intensive platform. Its public filings are widely monitored for institutional-quality growth and cyclical equity ideas.

This Fund
S&P 500
This Quarter Est. Return
+9.15%
1 Year Est. Return
+11.24%
3 Year Est. Return
+97.96%
5 Year Est. Return
+103.31%
10 Year Est. Return
+433.41%
AUM
$22.9B
AUM Growth
-$933M
Cap. Flow
-$2.63B
Cap. Flow %
-11.47%
Top 10 Hldgs %
48.14%
Holding
80
New
20
Increased
16
Reduced
25
Closed
18
Avg Time Held
0.5 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
0.6 years

Sector Composition

Rank Sector Weight
1 Healthcare 34.24%
2 Communication Services 12%
3 Consumer Discretionary 11.53%
4 Financials 9.77%
5 Energy 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
WBA icon
1
DELISTED
Walgreens Boots Alliance
WBA
$1.49B 6.52%
20,137,154
-3,968,687
-16% -$277M
2013 Q4
2 quarters
BHC icon
2
Bausch Health
BHC
$3.26B
$1.49B 6.51%
11,830,932
+2,534,789
+27% +$323M
2013 Q2
4 quarters
ILMN icon
3
Illumina
ILMN
$31.8B
$1.43B 6.23%
8,216,644
-897,856
-10% -$134M
2013 Q4
2 quarters
LOW icon
4
Lowe's Companies
LOW
$125B
$1.1B 4.8%
22,907,968
+4,795,400
+26% +$224M
2013 Q3
3 quarters
LYB icon
5
LyondellBasell Industries
LYB
$18.9B
$1.05B 4.59%
10,771,736
-2,087,268
-16% -$199M
2013 Q2
4 quarters
TMO icon
6
Thermo Fisher Scientific
TMO
$257B
$976M 4.26%
8,271,280
-1,397,359
-14% -$164M
2013 Q2
4 quarters
PXD icon
7
DELISTED
Pioneer Natural Resources
PXD
$936M 4.09%
4,072,836
+2,435,300
+149% +$503M
2014 Q1
1 quarter
BIDU icon
8
Baidu
BIDU
$23.6B
$875M 3.82%
4,681,428
+442,470
+10% +$72.4M
2013 Q3
3 quarters
COF icon
9
Capital One
COF
$111B
$840M 3.67%
10,165,787
-734,630
-7% -$57.1M
2013 Q2
4 quarters
REGN icon
10
Regeneron Pharmaceuticals
REGN
$97.8B
$837M 3.65%
2,963,456
+1,911,656
+182% +$567M
2014 Q1
1 quarter
MA icon
11
Mastercard
MA
$560B
$722M 3.15%
9,820,830
+2,088,010
+27% +$155M
2013 Q2
4 quarters
MON
12
DELISTED
Monsanto
MON
$721M 3.15%
5,780,631
+2,683,100
+87% +$314M
2013 Q2
4 quarters
MHK icon
13
Mohawk Industries
MHK
$8.63B
$629M 2.74%
4,543,823
+2,030,935
+81% +$274M
2013 Q4
2 quarters
MDLZ icon
14
Mondelez International
MDLZ
$84.3B
$598M 2.61%
15,898,877
+586,202
+4% +$21.4M
2013 Q4
2 quarters
MU icon
15
Micron Technology
MU
$797B
$583M 2.55%
17,699,068
-2,968,549
-14% -$80.9M
2013 Q2
4 quarters
NFLX icon
16
Netflix
NFLX
$246B
$580M 2.53%
+92,226,190
New +$499M
2014 Q2
0 quarters
V icon
17
Visa
V
$775B
$578M 2.52%
10,978,612
-3,992
-0% -$209K
2013 Q2
4 quarters
TWX
18
DELISTED
Time Warner
TWX
$553M 2.41%
7,872,453
-14,708,031
-65% -$967M
2013 Q2
4 quarters
CP icon
19
Canadian Pacific Kansas City
CP
$81.1B
$544M 2.38%
15,021,210
-5,094,025
-25% -$167M
2013 Q4
2 quarters
TFCFA
20
DELISTED
Twenty-First Century Fox Class A
TFCFA
$465M 2.03%
13,229,932
-24,703,924
-65% -$840M
2013 Q3
3 quarters
SLXP
21
DELISTED
Salix Pharmaceuticals
SLXP
$356M 1.56%
2,889,303
+1,337,537
+86% +$148M
2014 Q1
1 quarter
CAM icon
22
DELISTED
Cameron International
CAM
$331M 1.45%
4,889,535
-2,921,684
-37% -$188M
2013 Q3
3 quarters
KSU
23
DELISTED
Kansas City Southern
KSU
$326M 1.42%
3,027,831
+1,190,206
+65% +$123M
2014 Q1
1 quarter
ALXN
24
DELISTED
Alexion Pharmaceuticals
ALXN
$313M 1.37%
2,006,092
+169,434
+9% +$26.8M
2013 Q2
4 quarters
STZ icon
25
Constellation Brands
STZ
$24.3B
$292M 1.27%
3,308,832
-3,705,306
-53% -$306M
2013 Q3
3 quarters

Similar funds

Andreas Halvorsen's Q2 2014 Portfolio in Review

As of Q2 2014, Andreas Halvorsen held 80 positions worth $22.9B, down 3.9% from $23.8B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Andreas Halvorsen withdrew a net $2.63B in Q2 2014, closing 18 positions and reducing 25 holdings. Its most notable exit was AIG, an estimated $316M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 30% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Andreas Halvorsen opened a new position in Netflix worth $580M.

  • Andreas Halvorsen's largest Q2 2014 buy was Netflix: 92,226,190 shares worth $580M.
  • Andreas Halvorsen added most to Regeneron Pharmaceuticals in Q2 2014, an estimated $567M increase.
  • Andreas Halvorsen's biggest Q2 2014 reduction was Time Warner, cutting an estimated $967M.
  • Andreas Halvorsen fully exited AIG in Q2 2014, selling an estimated $316M.
  • Andreas Halvorsen's ten largest holdings make up 48% of its $22.9B portfolio in Q2 2014.
  • Andreas Halvorsen opened 20 new positions and closed 18 in Q2 2014.
  • Andreas Halvorsen's portfolio value fell 3.9% quarter-over-quarter to $22.9B.

Based on Viking Global Investors's 13F filing for Q2 2014, filed 14 Aug 2014.